Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Oct 2018. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
110922401000001111 | Aminophylline 225mg modified-release tablets (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
110922501000001110 | Aminophylline 225mg modified-release tablets | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Aminophylline 225mg modified-release tablets 60 tablet | Has VMP | True | Aminophylline 225mg modified-release tablets | Inferred relationship | Existential restriction modifier | |
Aminophylline 225mg modified-release tablets 56 tablet | Has VMP | True | Aminophylline 225mg modified-release tablets | Inferred relationship | Existential restriction modifier | |
Aminophylline 225mg modified-release tablets (Unichem Plc) | Is a | True | Aminophylline 225mg modified-release tablets | Inferred relationship | Existential restriction modifier | |
Norphyllin SR 225mg tablets (IVAX Pharmaceuticals UK Ltd) | Is a | True | Aminophylline 225mg modified-release tablets | Inferred relationship | Existential restriction modifier | |
Amnivent-225 SR tablets (Ashbourne Pharmaceuticals Ltd) | Is a | True | Aminophylline 225mg modified-release tablets | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets